Vor Biopharma Inc. (VOR) Misses Q1 EPS by 6c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M